Results 1 to 10 of about 547,171 (369)
Upstream Regulators of Fibroblast Growth Factor 23
Frontiers in Endocrinology, 2021 Fibroblast growth factor 23 (FGF23) has been described as an important regulator of mineral homeostasis, but has lately also been linked to iron deficiency, inflammation, and erythropoiesis. FGF23 is essential for the maintenance of phosphate homeostasis
Danielle M. A. Ratsma +2 more
doaj +2 more sources
Effects of Single Vitamin D Injection (200,000 Units) on Serum Fibroblast Growth Factor 23 and Sclerostin Levels in Subjects with Vitamin D Deficiency [PDF]
Endocrinology and Metabolism, 2017 BackgroundVitamin D deficiency remains common in all age groups and affects skeletal and non-skeletal health. Fibroblast growth factor 23 is a bone-derived hormone that regulates phosphate and 1,25-dihydroxyvitamin D homeostasis as a counter regulatory ...
Dongdong Zhang +5 more
doaj +4 more sources
Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia [PDF]
Endocrinology and MetabolismFibroblast growth factor 23 (FGF23) is a pivotal humoral factor for the regulation of serum phosphate levels and was first identified in patients with autosomal dominant hypophosphatemic rickets and tumor-induced osteomalacia (TIO), the most common form ...
Nobuaki Ito, Naoko Hidaka, Hajime Kato
doaj +2 more sources
Journal of Medical Case Reports, 2020 Background Neurofibromatosis type 1 is characterized by multiple café au lait spots and cutaneous and plexiform neurofibromas, and is one of the most common autosomal dominant hereditary disorders caused by mutations of the neurofibromatosis type 1 tumor
Takahiko Obo +4 more
doaj +2 more sources
Frontiers in Medicine, 2023 IntroductionA negative association between C-terminal fibroblast growth factor 23 (cFGF23) and hemoglobin (Hb) levels has been reported in patients with predialysis chronic kidney disease.
Yu-Wei Fang +9 more
doaj +1 more source
Tumor-induced osteomalacia: Easing the diagnosis with fibroblast growth factor 23
APIK Journal of Internal Medicine, 2022 Tumor-induced osteomalacia (TIO), is a rare paraneoplastic syndrome resulting in bone pain, muscle weakness, and recurrent fractures. Hypophosphatemia, hyperphosphaturia, low 1, 25 dihydroxyVitamin D, and normal serum calcium are noted.
Mala Dharmalingam, Lohit Kumbar
doaj +1 more source
Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism
PLoS ONE, 2022 This ad hoc analysis of a previously conducted phase 3 head-to-head comparison study of evocalcet and cinacalcet in secondary hyperparathyroidism patients undergoing maintenance hemodialysis evaluated the efficacy and safety of combined once-daily oral ...
Takashi Shigematsu +5 more
doaj +2 more sources
Il Fibroblast Growth Factor-23 (FGF-23)
Giornale di Clinica Nefrologia e Dialisi, 2018 Negli ultimi due decenni, l'identificazione delle proprietà biologiche del Fibroblast Growth Factor 23 (FGF23) ha notevolmente ampliato le conoscenze sulla regolazione endocrina e paracrina dell'omeostasi dei fosfati e sulle relazioni intercorrenti tra ...
D. Rendina +4 more
doaj +1 more source
Fibroblast Growth Factor-23 (FGF-23) e Sindrome Cardiorenale
Giornale di Clinica Nefrologia e Dialisi, 2015 non disponibile (Cardionephrology)
Luca Di Lullo +6 more
doaj +1 more source
MicroRNA-297a regulates vascular calcification by targeting fibroblast growth factor 23 [PDF]
Iranian Journal of Basic Medical Sciences, 2016 Objective(s): Vascular calcification is one the major characteristics in patients with various types of chronic inflammatory disorders. MiRNAs have been shown to be involved in many normal biological functions as well as diseases; however, their role in ...
Shouhua Zheng +6 more
doaj +1 more source